Second-quarter earnings gave ammunition to both bulls and bears. Let’s review a few of the main takeaways of reporting season. To start, returns have been mixed over the last several weeks. Returns ...

The year's second quarter was a defining period for digital assets. The industry converged at events like Consensus, held in May in Toronto, where discussions heavily focused on critical themes like ...

MillerKnoll, Inc. is upgraded to a Buy as 2026 is poised for a turnaround, driven by rising demand and operational improvements. MLKN's Q2 ’26 results showed sequential order growth, margin ...

Everyone's rushing into stablecoins, but the numbers look... the same. In Q2, it felt like you couldn’t go a day without a major stablecoin announcement. JPMorgan launched its USD Deposit Token on ...

The stock and bond markets got off to a rough start in the second quarter of 2024, with the outlook dimming for Federal Reserve interest rate cuts against a backdrop of stubbornly high inflation.

Cardinal Health is upgraded to a buy after Q2 2026 delivered robust revenue, margin expansion, and raised full-year guidance. Q2 revenue grew 19% YoY to $65.6B, with non-GAAP EPS up 36% and ...

HCLTech Ltd.'s second-quarter revenue and operating income met estimates, with analysts largely bullish on the stock. The management revised service revenue guidance to 4–5% (from 3–5%) while EBIT and ...